Detalhe da pesquisa
1.
Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study.
Diabetes Obes Metab
; 22(7): 1176-1186, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32128957
2.
Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes.
Diabetes Obes Metab
; 22(8): 1292-1301, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32175655
3.
Predictive factors associated with three years of response to HbA1c goals with exenatide QW or insulin glargine: Post-hoc analysis of the DURATION-3 study.
Diabetes Obes Metab
; 21(4): 1049-1053, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30520252
4.
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.
Diabetes Obes Metab
; 21(11): 2429-2439, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31264757
5.
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline.
BMJ Open Diabetes Res Care
; 10(1)2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35042751
6.
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.
BMJ Open Diabetes Res Care
; 9(1)2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34172436
7.
Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide.
Diabetes Care
; 42(9): 1733-1741, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31320446
8.
Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.
Regul Pept
; 151(1-3): 123-9, 2008 Nov 29.
Artigo
Inglês
| MEDLINE | ID: mdl-18675854
9.
The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.
Ann Intern Med
; 146(7): 477-85, 2007 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-17404349
10.
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
Clin Ther
; 29(11): 2333-48, 2007 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18158075
11.
Three-year efficacy and safety of exenatide once weekly: A pooled analysis of three trials.
J Diabetes Complications
; 31(9): 1415-1422, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28669463
12.
Early Pharmacodynamic Effects of Exenatide Once Weekly in Type 2 Diabetes Are Independent of Weight Loss: A Pooled Analysis of Patient-level Data.
Clin Ther
; 38(6): 1464-1473, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27126504
13.
Five-year efficacy and safety data of exenatide once weekly: long-term results from the DURATION-1 randomized clinical trial.
Mayo Clin Proc
; 90(3): 356-65, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25744115
14.
Assessment of pancreatic ß-cell function: review of methods and clinical applications.
Curr Diabetes Rev
; 10(1): 2-42, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24524730
15.
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial.
Lancet Diabetes Endocrinol
; 2(6): 464-73, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24731672
16.
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
N Engl J Med
; 353(20): 2192-4; author reply 2192-4, 2005 Nov 17.
Artigo
Inglês
| MEDLINE | ID: mdl-16291992
17.
Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1.
Expert Opin Drug Discov
; 8(2): 219-44, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23231438
18.
Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects.
Regul Pept
; 179(1-3): 77-83, 2012 Nov 10.
Artigo
Inglês
| MEDLINE | ID: mdl-22960288
19.
Safety of exenatide once weekly in patients with type 2 diabetes mellitus treated with a thiazolidinedione alone or in combination with metformin for 2 years.
Clin Ther
; 34(10): 2082-90, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23031623